EUnetHTA at ISPOR Prague. Issue Panels, IP17: HTA Level of Influence. EUnetHTA
In 2010, the ISPOR Annual European Congress had HTA as its main theme. EUnetHTA and its activities were in focus both at the Plenary Sessions
EUnetHTA at ISPOR Prague. Issue Panels, IP17: HTA Level of Influence
In 2010, the ISPOR Annual European Congress had HTA as its main theme. EUnetHTA and its activities were in focus both at the Plenary Sessions
Assessment of Health Technology in Europe: Taking Stock of the Inefficiencies
In 2010, the ISPOR Annual European Congress had HTA as its main theme. EUnetHTA and its activities were in focus both at the Plenary Sessions
A Stakeholder Perspective on HTA Inefficiencies in Europe and the HTA Joint Action Initiative
In 2010, the ISPOR Annual European Congress had HTA as its main theme. EUnetHTA and its activities were in focus both at the Plenary Sessions
Poster on Relative Effectiveness Assessment of Pharmaceuticals
In 2010, the ISPOR Annual European Congress had HTA as its main theme. EUnetHTA and its activities were in focus both at the Plenary Sessions
A Stakeholder Perspective on HTA Inefficiencies in Europe and the HTA Joint Action Initiative
In 2010, the ISPOR Annual European Congress had HTA as its main theme. EUnetHTA and its activities were in focus both at the Plenary Sessions
Relative Effectiveness Assessment of Pharmaceuticals: A EUnetHTA Joint Action Initiative
In 2010, the ISPOR Annual European Congress had HTA as its main theme. EUnetHTA and its activities were in focus both at the Plenary Sessions
The European network for HTA (EUnetHTA) Joint Action Strategy & Core Model
In 2010, the ISPOR Annual European Congress had HTA as its main theme. EUnetHTA and its activities were in focus both at the Plenary Sessions
Starting a new phase – European network for HTA Joint Action
The EUnetHTA Joint Action (European network for HTA Joint Action) grant agreement has been signed by the EU Executive Agency for Health and Consumers and
European Medicines Agency and EUnetHTA Joint Action Press Release
European Medicines Agency and EUnetHTA Joint Action start collaboration on European Public Assessment Report (EPAR) contribution to relative effectiveness assessments. Please find the press release